The next phase of real-world clinical experience with alefacept: the AWARE-2 registry - Innovaderm Research

CRO Services
Participate In a Study
About Us
Careers
Contact
FR

CRO Services
Participate In a Study
About Us
Careers
Contact
FR

Test

Post navigation

The AWARE study: methodology and baseline characteristics.

Efficacy outcomes in patients using alefacept in the AWARE study

CRO Services
Participate In a Study
About Us
Careers
Contact
FR

CRO Services
Participate In a Study
About Us
Careers
Contact
FR

Dermatology Clinic
3530 Saint-Laurent boulevard
Suite 400
Montreal, QC, H2X 2V1, Canada

© Innovaderm 2025. All rights reserved.

Facebook-f Instagram Linkedin